UF at ASCO 2020

UF abstracts at the 2020 ASCO Annual Meeting

Abstracts

*Name in bold are UF affiliated 

Assessing impact of inpatient rotations on resident interest in hematology-oncology

Authors: Bilal Farooqi, Lynne Meyer, Julia Lee Close, Jennifer Michelle Duff; Comprehensive Hematology Oncology, Brandon, FL; University of Florida, Gainesville, FL; University of Florida, Dept. of Medicine, Division of Hematology and Oncology, Gainesville, FL

Bleeding and thrombosis outcomes in patients with acute leukemia 

Authors: Amar Harry Kelkar, Asha R. Dhanarajan, Mona Arti Kelkar, John R. Wingard; University of Florida College of Medicine, Department of Medicine, Division of Hematology & Oncology, Gainesville, FL; Loyola University Medical Center, Department of Medicine, Division of Hematology/Oncology, Maywood, IL; Harvard T.H. Chan School of Public Health, Boston, MA

A systematic review of evidence for cannabis and cannabinoids as adjuvant therapy in palliative and supportive oncology care 

Authors: Sebastian Jugl, Shailina Keshwani, Lauren Adkins, Coy D. Heldermon, Almut Winterstein, Amie Goodin; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida; Center for Drug Evaluation and Safety (CoDES), Gainesville, FL; Health Science Center Library, University of Florida, Gainesville, FL; Department of Medicine, University of Florida, Gainesville, FL; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida; Center for Drug Evaluation and Safety (CoDES), Gainesvillle, FL

Clinicopathological and molecular biological characteristics of early-onset stage II/III colorectal adenocarcinoma: An analysis of 25 studies with 47,184 patients (pts) in the adjuvant colon cancer end points (ACCENT) database

Authors: Zhaohui Jin, Jesse G. Dixon, Hiral D. Parekh, Steven R Alberts, Greg Yothers, Carmen Joseph Allegra, Rachel Kerr, Daniel G. Haller, Aimery De Gramont, Takayuki Yoshino, Eric Van Cutsem, Chris Twelves, Julien Taieb, Leonard B. Saltz, Jean-François Seitz, Thierry Andre, Amit Mahipal, Richard M. Goldberg, Qian Shi, Thomas J. George; Mayo Clinic, Rochester, MN; Department of Health Science Research, Mayo Clinic, Rochester, MN; University of Florida Health Cancer Center, Gainesville, FL; NRG Oncology, and The University of Pittsburgh, Pittsburgh, PA; NSABP Foundation, Inc., and The University of Florida, Gainesville, FL; University of Oxford, Oxford, United Kingdom; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; Franco-British Institute, Levallois-Perret, France; National Cancer Center Hospital East, Kashiwa, Japan; University Hospitals Gasthuisberg Leuven, KU Leuven, Leuven, Belgium; St. James’s Hospital and The University of Leeds, Leeds, United Kingdom; Georges Pompidou European Hospital, Paris, France; Department of Colorectal Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; Hopital de la Timone, Marseille, France; Sorbonne University and Saint-Antoine Hospital, Paris, France; West Virginia University Cancer Institute, Morgantown, WV

NCI protocol 10250: A phase II study of temozolomide and olaparid for the treatment of advanced uterine leiomyosarcoma

Authors: Matthew Ingham, Jacob B Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Amber Burgess, Sosipatros Alexandros Boikos, Nam Bui, James Lin Chen, Julia Lee Close, Mahesh Seetharam, Premal H. Thaker, Gary K. Schwartz; Columbia University Irving Medical Center, New York, NY; Mayo Clinic, Rochester, MN; Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA; Mayo Clinic, Jacksonville, FL; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA; Virginia Commonwealth University Hospital, Richmond, VA; Stanford Cancer Institute, Palo Alto, CA; The Ohio State University, Columbus, OH; University of Florida, Gainesville, FL; Mayo Clinic Arizona, Scottsdale, AZ; Department of Gynecologic Oncology, Washington University School of Medicine, St. Louis, MO

Segmental chromosome aberrations and clinical response impact outcome of inss stage III patients ≥18 months with unfavorable histology and without MYCN amplification: A Children’s Oncology Group (COG) report 

Authors: Navin R. Pinto, Arlene Naranjo, Emily Hibbitts, Xiangming Ding, Rachelle Tibbetts, Rebekah Kennedy, Ruthann Pfau, Michael D. Hogarty, Susan G. Kreissman, Meredith Irwin, Julie R. Park, Shahab Asgharzadeh; Seattle Children’s Hospital, Seattle, WA; Children’s Oncology Group Statistics and Data Center, University of Florida, Gainesville, FL; Children’s Oncology Group, Gainsville, FL; University of Southern California, Los Angeles, CA; Children’s Hospital Los Angeles, Los Angeles, CA; Nationwide Biopathology Center, Columbus, OH; Children’s Hospital of Philadelphia, Philadelphia, PA; Duke University Medical Center, Durham, NC; The Hospital for Sick Children, Toronto, ON, Canada; Seattle Children’s Hospital and University of Washington School of Medicine, Seattle, WA

Molecular diagnostic testing patterns in patients (pts) with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) in the Connect MDS/AML Registry 

Authors: Tracy George, Jay L. Patel, Mehrdad Abedi, Christopher R. Cogle, Harry Paul Erba, Guillermo Garcia-Manero, David L. Grinblatt, Pavel Kiselev, Rami S. Komrokji, Chrystal Ursula Louis, Jaroslaw P. Maciejewski, Melissa Nifenecker, Daniel Aaron Pollyea, Gail J. Roboz, Michael R. Savona, Bart L. Scott, Mikkael A. Sekeres, David P. Steensma, Michael A. Thompson, Kathryn Foucar; University of Utah and ARUP Laboratories, Salt Lake City, UT; University of California, Davis Comprehensive Cancer Center, Sacramento, CA; University of Florida, Gainesville, FL; Duke University, Durham, NC; MD Anderson Cancer Center, Houston, TX; NorthShore University HealthSystem, Evanston, IL; Bristol-Myers Squibb, Summit, NJ; Moffitt Cancer Center, Tampa, FL; Cleveland Clinic, Cleveland, OH; University of Colorado, Aurora, CO; Weill Cornell University, New York, NY; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN; Fred Hutchinson Cancer Research Center, Seattle, WA; Dana-Farber Cancer Institute, Boston, MA; Advocate Aurora Health, Milwaukee, WI; University of New Mexico Health Sciences Center, Albuquerque, NM

 

Feasibility of developing a Twitter journal club for hematology/oncology education

Authors: Elizabeth Henry, Devika Govind Das, Martina Cathryn Murphy; Loyola University Medical Center, Maywood, IL; University of Alabama, Birmingham, AL; Shands/Univ of Florida, Gainesville, FL

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stay II colon cancer: NRG-GI005 (COBRA) 

Authors: Van K. Morris, Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal, Patrick M Boland, Dustin A. Deming, Aaron James Scott, Howard John Lim, Norman Wolmark, Thomas J. George; NRG Oncology, and UT-MD Anderson Cancer Center, Houston, TX; NRG Oncology, and The University of Pittsburgh, Pittsburgh, PA; NRG Oncology and University of Texas MD Anderson Cancer Ctr, Houston, TX; NRG Oncology, and The University of Pittsburgh Cancer Institute, Pittsburgh, PA; NRG Oncology, and University of Pittsburgh School of Medicine, Pittsburgh, PA; NRG Oncology, and Baylor College of Medicine, Houston, TX; Rutgers Cancer Institute of New Jersey, and the Alliance, New Brunswich, NJ; University of Wisconsin Carbone Cancer Center, and ECOG-ACRIN, Madison, WI; University of Arizona Cancer Center, and SWOG, Tucson, AZ; British Columbia Cancer Vancouver, and CCTG Co-chair, Vancouver, BC, Canada; NRG Oncology, and The University of Florida Health Cancer Center, Gainesville, FL

Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032

Authors: Ami Vijay Desai, Andrew Gilman, Mehmet Fevzi Ozkaynak, Arlene Naranjo, Wendy B London, Sheena Cretella Tenney, Malcolm Smith, Nita Seibel, Hiroyuki Shimada, Katherine K. Matthay, Susan Lerner Cohn, John M. Maris, Rochelle Bagatell, Paul M. Sondel, Julie R. Park, Alice L. Yu; University of Chicago Medical Center, Chicago, IL; PRA Health Sciences, Raleigh, NC; New York Medical College, Cross River, NY; Children’s Oncology Group Statistics and Data Center, University of Florida, Gainesville, FL; Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA; Children’s Oncology Group Statistics and Data Center, Gainesville, FL; National Cancer Institute, Bethesda, MD; Stanford University Medical Center, Stanford, CA; University of California San Francisco, San Francisco, CA; Children’s Hospital of Philadelphia, Philadelphia, PA; University of Wisconsin, Madison, WI; Seattle Children’s Hospital and University of Washington School of Medicine, Seattle, WA; University of California, San Diego, CA

Patterns of Twitter use among trainees in hematology-oncology related areas 

Authors: Miguel Gonzalez Velez, Narjust Duma, Daniel Cabrera, Ariela L. Marshall, Deanna J. Attai, Merry Jennifer Markham, Rafael Fonseca; Mayo Clinic Arizona, Phoenix, AZ; Mayo Clinic, Rochester, MN; Mayo Clinic Rochester, Rochester, MN; Division of Hematology, Mayo Clinic, Rochester, MN; David Geffen School of Medicine at UCLA, Los Angeles, CA; University of Florida, Gainesville, FL; Mayo Clinic in Arizona, Phoenix, AZ

Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms (NCT03207347)

Authors: azka ali, David L. DeRemer, Ji-Hyun Lee, Hiral D. Parekh, Stephen Staal, Merry Jennifer Markham, Karen Colleen Daily, Bruce K. Stechmiller, Dennie V. Jones, Julia Lee Close, Martina Cathryn Murphy, Frederic J. Kaye, Carmen Joseph Allegra, Robert A. Hromas, Thomas J. George; University of Florida College of Medicine Department of Internal Medicine, Gainesville, FL; University of Florida/UF Health Cancer Center, Gainesville, FL; University of Florida, Gainesville, FL; University of Florida Health Cancer Center, Gainesville, FL; Univ of Florida, Gainesville, FL; UF Health Cancer Center, Gainesville, FL; Shands/Univ of Florida, Gainsville, FL; NSABP Foundation, Inc., and The University of Florida Health Cancer Center, Gainesville, FL; University of Texas Health Science Center at San Antonio, San Antonio, TX

Effect of beta block use in soft tissue sarcomas 

Authors: Edward De Leo, Wissam Hanayneh, Chintan Shah, Yu Wang, Ji-Hyun Lee, Julia Lee Close, Nam H. Dang; University of Florida, Gainesville, FL; University Of Florida, Gainesville, FL; University of Florida Health Cancer Center, Gainesville, FL

Systematic analysis of extracting data on advance directive from patient electronic health records in terminal oncology patients 

Authors: William Paul Skelton, Jason Scott Starr, Kiarash Rahmanian, Robert Guenther, William L. Allen, Thomas J. George, Ray E. Moseley; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Mayo Clinic, Jacksonville, FL; University of Florida, Gainesville, FL; University of Florida Health Cancer Center, Gainesville, FL

Primary cutaneous diffuse large B-cell lymphoma, leg-type: The Mayo Clinic experience 

Authors: Muhamad Alhaj Moustafa, Ricardo Daniel Parrondo, Nicole Gannon, Jacquelyn Hastings, Karan Seegobin, Bradford Hoppe, David M Menke, Mohamed Kharfan-Dabaja, Ernesto Ayala, Liuyan Jiang, Han W. Tun; Mayo Clinic, Jacksonville, FL; Mayo Clinic Florida, Jacksonville, FL; University of Florida College of Medicine, Jacksonville, FL

Multiscale omic assessment of EWSR1-NFATc2 fusion positive sarcomas to identify conserved fusion breakpoint and activation of the mTOR pathway 

Authors: Nathan David Seligson, Richard D Maradiaga, Colin W. Stets, Howard Katzenstein, Sherri Z. Millis, John L. Hays, James Lin Chen; University of Florida, Jacksonville, FL; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH; The Ohio State Comprehensive Cancer Center, Columbus, OH; Nemour’s Children’s Clinics, Jacksonville, FL; Foundation Medicine, Inc., Cambridge, MA; The Ohio State University Wexner Medical Center, Columbus, OH; The Ohio State University, Columbus, OH

Enrollment barriers of adolescents and young adults (AYA) on the non-chemotherapy arm of ARST1321

Authors: Lisa M. Kopp, Damon R. Reed, Safia K. Ahmed, Wendy Allen-Rhoades, Viswatej Avutu, Yen-Lin Chen, Lara E. Davis, Bree Ruppert Eaton, Douglas S. Hawkins, Daniel J. Indelicato, Shreyaskumar Patel, R. Lor Randall, Denise K. Reinke, Richard F. Riedel, Thomas Scharschmidt, Katherine Anne Thornton, Dian Wang, Katherine A. Janeway, Aaron R. Weiss; University of Arizona, Tucson, AZ; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Mayo Clinic, Rochester, MN; Baylor Coll of Medcn/Texas Childrens Hosp, Pearland, TX; Memorial Sloan Kettering Cancer Center, New York, NY; Massachusetts General Hospital, Boston, MA; Oregon Health and Science University, Portland, OR; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Seattle Children’s Hospital, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA; University of Florida Health Proton Therapy Institute, Jacksonville, FL; The University of Texas MD Anderson Cancer Center, Houston, TX; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; SARC, Ann Arbor, MI; Duke University Medical Center, Durham, NC; Ohio State University, Columbus, OH; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Bethesda, MD; Rush University Medical Center, Chicago, IL; Dana-Farber Cancer Institute, Boston, MA; Maine Medical Center, Portland, ME

Reproductive risk factor patterns in the Caribbean affecting breast cancer age of onset 

Authors: Alex Sanchez-Covarrubias, Danielle Cerbon, Priscila Barreto Coelho, Talia Donenberg, Mohammad R Akbari, Jameel Ali, Raleigh Butler, Duvaughn Curling, Leah Dodds, Vincent A. DeGennaro, Hedda Dyer, Darron Andrew Calvin Halliday, Steven Narod, Isildinha N Reis, Matthew Schlumbrecht, Theodore A. Turnquest, Gillian Wharfe, Judith Hurley, Sophia George; University of Miami/Jackson Memorial Hospital, Miami, FL; University of Miami, Miami, FL; Jackson Memorial Hospital/University of Miami, Miami, FL; Women’s College Research Institute, Women’s College Hospital, University of Toronto, Toronto, ON, Canada; Women’s Health Unit, St. James Medical Complex, Trinidad & Tobago, Trinidad and Tobago; Princess Margaret Hospital, Nassau, Bahamas; University of Miami, Miller School of Medicine, Miami, FL; Univ of Florida, Gainesville, FL; Ross University, Commonwealth of Dominica, Roseau, Dominica; Women’s College Research Institute, Toronto, ON, Canada; University of Miami-Sylvester Comprehensive Cancer Center, Miami, FL; Mona, University of West Indies, Kingston, Jamaica; University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL

Epidemiological profile of cancers among adolescent and young adult patients of a Haitian cancer program 

Authors: Joseph Bernard, Pascale Constant, Rebecca Henderson, Lynn Gabrielle Alexis, Doukens Patrick Gilbert, Lenz Sacha Christyl Pierre, Vincent A. DeGennaro; Innovating Health International, Port-Au-Prince, Haiti; Université Notre Dame d’Haïti, Faculté de Médecine et des Sciences de la Santé, Port-Au-Prince, Haiti; University of Florida, Gainesville, FL; Université Notre Dame d’Haiti, Faculté de Medecine et des Sciences de la Santé, Port-Au-Prince, Haiti

HORIZON (OP-106): An exploratory analysis of time-to-next treatment (TTNT) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) who received melflufen plus dexamethasone (dex)

Authors: Maria-Victoria Mateos, Albert Oriol, Alessandra Larocca, Joan Blade, Michele Cavo, Paula Rodríguez Otero, Xavier Leleu, John W. Hiemenz, Hani Hassoun, Cyrille Touzeau, Adrian Alegre, Agne Paner, Christopher Maisel, Amitabha Mazumder, Anastasios Raptis, Johan Harmenberg, Stojan Zavisic, Sara Thuresson, Oskar Öhman, Paul G. Richardson; University Hospital of Salamanca/IBSAL/Cancer Research Center- IBMCC (USAL-CSIC), Salamanca, Spain; Institut d’Investigació Contra la Leucèmia Josep Carreras and Institut Català d’Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain; A.O.U. Città della Salute e della Scienza di Torino-S.C. Ematologia U, Torin, Italy; Hospital Clínic de Barcelona-Servicio de Onco-Hematología, Barcelona, Spain; Policlinico S. Orsola Malpighi, Bologna, Italy; Clinica Universidad de Navarra-Pamploma, Navarra, Spain; CHU de Poitiers, Poitiers, France; University of Florida Health Cancer Center, Gainesville, FL; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer, New York, NY; Centre Hospitalier Universitaire, Nantes, France; Hospital Universitario La Princesa, Madrid, Spain; Assoc In Med Onc, Bolingbrook, IL; Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX; The Oncology Institute of Hope and Innovation, Glendale, CA; UPMC Hillman Cancer Center, Pittsburg, PA; Oncopeptides AB, Stockholm, Sweden; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

A phase II/III randomized, blinded study of tozuleristide for fluorescence imaging detection during neurosurgical resection of pediatric primary central nervous system (CNS) tumors: PNOC012 (Pacific Pediatric Neuro-oncology Consortium)

Authors: Sarah Leary, Jason E. Blatt, Alan R. Cohen, Kenneth J. Cohen, Bonnie Cole, Lance Governale, Nalin Gupta, Jason S. Hauptman, Eric M. Jackson, Meysam A. Kebriaei, Cassie Kline, Andrew Kobets, Amy Lee, Dennis Michael Miller, Sabine Mueller, Jeff Ojemann, Michael Prados, Maryam Rahman, Jason N. Wright, Anne Elizabeth Bendel, BB-006/PNOC012 Study Group

Concordance between independent and investigator assessment of disease-free survival (DFS) in the APACT trial

Authors: Michele Reni, Hanno Riess, Eileen Mary O’Reilly, James Andrew Reeves, Elena Chiorean, Thomas J. George, Werner Scheithauer, Artru Pascal, Markus Lerch, Warren S. Brenner, Yoo-Joung Ko, Josep Tabernero, Eric Van Cutsem, Philip Agop Philip, David Goldstein, Jordan Berlin, Andrew Biankin, Margaret A. Tempero

A phase III randomized trial of pleurectomy/decortication plus chemotherapy with or without adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for malignant pleural mesothelioma (MPM) (NRG LU-006)

Authors: Andreas Rimner, Marjorie Glass Zauderer, Ellen Yorke, Charles B. Simone, Ritu R. Gill, K Ranh Voong, Tobias Peikert, Ming Sound Tsao, Zuofeng Li, Valerie W. Rusch, Jeffrey Bradley

Share

Categories

Front Page

Read This Next

Back to Issue Home

Cover for Monthly HAAs: Grants Issue

Monthly HAAs: Grants